Secondary Logo

Journal Logo

Articles by Ian Frank

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody

Edupuganti, Srilatha; Mgodi, Nyaradzo; Karuna, Shelly T.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(1):671-679, May 1, 2021.

Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research

Schnoll, Robert A.; Thompson, Morgan; Serrano, Katrina; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 80(2):e36-e40, February 1, 2019.

Individual and Community Factors Associated With Geographic Clusters of Poor HIV Care Retention and Poor Viral Suppression

Eberhart, Michael G.; Yehia, Baligh R.; Hillier, Amy; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 69:S37-S43, May 1, 2015.

Feasibility of Identifying a Cohort of US Women at High Risk for HIV Infection for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 906

Koblin, Beryl A.; Metch, Barbara; Novak, Richard M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(2):239-244, June 1, 2013.

Telephone Support to Improve Antiretroviral Medication Adherence: A Multisite, Randomized Controlled Trial

Reynolds, Nancy R; Testa, Marcia A; Su, Max; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(1):62-68, January 1, 2008.

Prevalence, Risk Factors, and Outcomes for Occult Hepatitis B Virus Infection Among HIV-Infected Patients

Re, Vincent Lo III; Frank, Ian; Gross, Robert; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(3):315-320, March 1, 2007.

Incidence and Risk Factors for Weight Loss During Dual HIV/Hepatitis C Virus Therapy

Re, Vincent Lo III; Kostman, Jay R; Gross, Robert; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(3):344-350, March 1, 2007.

Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248)

Vogler, Mary A.; Teppler, Hedy; Gelman, Rebecca; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(1):576-587, May 1st, 2004.

A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease

Shepp, David H.; Ramirez-Ronda, Carlos; Dall, Lawrence; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 15(4):283-288, August 1, 1997.